RecruitingPhase 2NCT07043322

Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Tanta University
Intervention: Coasting(procedure)
Enrollment: 150 target
Eligibility: 20-35 years · FEMALE
Timeline: 2025 – 2026

Study locations (1)

Mostafa Bahaa, Damietta, New Damietta, Egypt

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07043322 on ClinicalTrials.gov

← Back to all trials